ARTICLE | Company News
DFH Pharma, National Cancer Institute deal
January 16, 2012 8:00 AM UTC
The institute partnered with DFH Pharma to develop second-generation inhibitors of the maturation of HIV gag polyprotein identified by DFH to treat all strains of HIV infection. The institute will ev...